Target intelligence / Profile preview

Ribosomal protein L6 pseudogene 23 (RPL6P23)

Target
RPL6P23
Molecular classification
Other, Pseudogene
01

Overview

Ribosomal protein L6 pseudogene 23 is classified as a pseudogene, which means it is a genomic DNA sequence similar to a functional gene but generally non-functional; it does not produce a functional protein. RPL6P23 is related by sequence to the gene encoding ribosomal protein L6, an essential component of the 60S ribosomal subunit, but RPL6P23 itself is not expressed as a protein and does not have a known biological or disease-associated function in humans. It is not considered a therapeutic target, and there are no known drugs, biomarkers, or safety concerns associated with it. RPL6P23 was catalogued based on its sequence similarity to the functional RPL6 gene, but functions only as a processed pseudogene and not as an active gene product. There is no evidence or mention in scientific resources of direct involvement in disease, drug interaction, or other cellular functions.

Other names
RPL6P23

Beyond the preview

Go deeper on Ribosomal protein L6 pseudogene 23 (RPL6P23).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ribosomal protein L6 pseudogene 23 (RPL6P23).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call